Some adults in the Coachella Valley may qualify for GLP-1 weight loss drugs through a recently launched Medicare program. Medicare launched a temporary GLP-1 Bridge Program on July 1, which allows ...

Patterns differ among medication classes; potential mechanisms need more research ...

A common diabetes drug may help slow age-related vision loss, giving researchers a promising new clue for protecting eyesight ...

No difference in insulin discontinuation rates seen among three glucose-lowering classes ...

Groundbreaking research has shown that some people with type 2 diabetes can achieve remission through intensive lifestyle ...

These risks are significantly exacerbated if a Type 2 diabetes diagnosis is added to the mix, says Md Mohaimenul Islam, research assistant professor in the Department of Pharmacy Practice in the UB ...

Medicare will start the GLP-1 Bridge program July 1. Older adults who qualify for the weight-loss drugs will pay a monthly $50 copay.

The advent of an immunotherapy to delay type 1 diabetes and more potential treatments in the pipeline have shifted the way ...

A diabetes drug was linked to a surprising effect on the risk of dementia.

A new report states that older adults using GLP-1 drugs may have a higher risk of loss of muscle mass, malnutrition, ...

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.

Rising healthcare costs are one of the biggest challenges facing Massachusetts communities. As WAMC reports, weight loss ...